3 latest FDA approvals

Here are the three latest drugs or medical devices approved by the FDA this week.

Advertisement

1. The Resolute Onyx 2.0 mm stent, which is the smallest drug-eluding stent available in the U.S. market, can be used to treat coronary blood-vessel blockages.

2. Verzenio, in combination with an aromatase inhibitor, is a treatment for advanced or metastatic breast cancer in postmenopausal women.

3. ZTlido, a non-opoid painkiller patch, can be used to treat postherpetic neuralgia, a common complication of shingles characterized by burning pain.

More articles on supply chain:
Why a better hospital supply chain starts with better relationships
Teva shutters offices in New York City, Washington D.C., as part of cost cutting plan
Walgreens, AmerisourceBergen reportedly end takeover discussions with no deal

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.